Researchers identify new treatment target for genetic epilepsy
The rare neurodevelopmental condition CDKL5 is characterised by early-onset epilepsy
Read More
Tag: Loulou Foundation
Abcam and Loulou Foundation form CDKL5 deficiency disorder partnership
Abcam has announced a research collaboration with the Loulou Foundation to discover new tools to advance research for the development of therapeutics for CDKL5 Deficiency Disorder.
Read More
- Liverpool and McMaster University announce £300,000 strategic research partnership
- Study finds link between malaria parasites developing antimalarial drug resistance
- Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients
- Closed Loop and Pharmanovia investigate precision medicine combination in hypertension
- US study reveals interferon combinations cause lupus symptoms and affect treatment
